GL0034 (Utreglutide), a novel, long acting, glucagon-like peptide 1 receptor agonist (GLP-1 RA), results of a phase 1 study in healthy individuals

被引：0

作者：

Thennati, Rajamannar ^{[1
]}

Burade, Vinod ^{[1
]}

Natarajan, Muthukumaran ^{[1
]}

Shahi, Pradeep ^{[1
]}

Nagaraja, Ravishankara ^{[1
]}

Panchal, Satish ^{[1
]}

Agrawal, Sudeep ^{[1
]}

Jandrain, Bernard ^{[2
]}

Duvauchelle, Thierry ^{[3
]}

Pratley, Richard E. ^{[4
]}

Thorens, Bernard ^{[5
]}

Vilsboll, Tina ^{[6
]}

机构：

[1] Sun Pharmaceut Ind Ltd, High Impact Innovat Sustainable Hlth Solut HISHS, Vadodara, India

[2] Acad Hosp Liege, ATC Co, Clin Pharmacol Unit, Nutr & Metab Disorders, Liege, Belgium

[3] Phaster1, Paris, France

[4] AdventHlth Translat Res Inst, Orlando, FL USA

[5] Univ Lausanne, Ctr Integrat Genom, Lausanne, Switzerland

[6] Univ Copenhagen, Steno Diabet Ctr, Clin Res, Copenhagen, Denmark

来源：

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

THU-419

引用

页码：S607 / S608

页数：2